| Drug Name |
Ceftizoxime sodium |
| Drug ID |
BADD_D00403 |
| Description |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
| Indications and Usage |
Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria. |
| Marketing Status |
approved; withdrawn |
| ATC Code |
J01DD07 |
| DrugBank ID |
DB01332
|
| KEGG ID |
D00923
|
| MeSH ID |
D015296
|
| PubChem ID |
23663938
|
| TTD Drug ID |
D0Y7BD
|
| NDC Product Code |
Not Available |
| UNII |
26337D5X88
|
| Synonyms |
Ceftizoxime | Ceftizoxime Sodium | Sodium, Ceftizoxime | Ceftizoxime Monosodium Salt | Monosodium Salt, Ceftizoxime | Salt, Ceftizoxime Monosodium | SKF-88373 | SKF 88373 | SKF88373 | FR-13749 | FR 13749 | FR13749 | SK&F 88373-2 | SK&F 88373 2 | SK&F 883732 | Cefizox | FK749 | FK-749 | FK 749 |
